Catalyst Pharmaceuticals, Inc.
CPRXDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001369568
Catalyst Pharmaceuticals, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 395 institutions reported holding it in 13F filings for Q2 2026, worth $3.39B in total; Soros Fund Management was the only superinvestor holding it.
Superinvestors holding CPRX, Q2 2026
1 superinvestor reports holding Catalyst Pharmaceuticals, Inc. on Form 13F, worth $10.8M in total. Weight is Catalyst Pharmaceuticals, Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Soros Fund ManagementGeorge Soros | 0.1% | 344,593 | $10.8M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CPRX each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
- New
- Soros Fund Management
- Sold out
- Fundsmith
Q1 2026
1 superinvestor holding at quarter end
- Reduced
- Fundsmith (−74.9%)
Q3 2025
1 superinvestor holding at quarter end
- Added
- Fundsmith (+24.2%)
Q2 2025
1 superinvestor holding at quarter end
- Added
- Fundsmith (+25.9%)
Q1 2025
1 superinvestor holding at quarter end
- New
- Fundsmith
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q2 2021
1 superinvestor holding at quarter end